Erratum: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: A randomized phase II trial by the prostate cancer clinical trials consortium (Investigational New Drugs DOI: 10.1007/s10637-010-9420-8)

  • Deborah A. Bradley
  • , Stephanie Daignault
  • , Charles J. Ryan
  • , Robert S. DiPaola
  • , Kathleen A. Cooney
  • , David C. Smith
  • , Eric Small
  • , Paul Mathew
  • , Mitchell E. Gross
  • , Mark N. Stein
  • , Alice Chen
  • , Kenneth J. Pienta
  • , June Escara-Wilke
  • , Gerald Doyle
  • , Mahmoud Al-Hawary
  • , Evan T. Keller
  • , Maha Hussain

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: A randomized phase II trial by the prostate cancer clinical trials consortium (Investigational New Drugs DOI: 10.1007/s10637-010-9420-8)'. Together they form a unique fingerprint.